News
-
Valley backers fuel battery startup’s $multibillion charge
Nyobolt, a thrusting young Cambridge battery company that has developed a new material to deliver ultra-high power, has raised $10 million in a... Read More
-
Featurespace invents next generation of Machine Learning
Featurespace’s Cambridge R & D team has mined previously untapped capability in machine learning and behavioural technology to provide... Read More
-
Quantum computing enters cancer arena with Cambridge-California pact
An historic Cambridge-California alliance will see quantum computing deployed to discover new cancer drugs – possibly for the first time.... Read More
-
Growth in the DNA for Camena Bioscience
Thrusting life science company Camena Bioscience has renewed its existing lease at Chesterford Research Park’s Science Village Building for a further... Read More
-
Exports drive fresh boom at Tristel plc
A surge in overseas sales spurred bug busting Newmarket company Tristel plc to a 20 per cent rise in revenues in the six months to December 31. The... Read More
-
Cambridge researchers lead new era for MS treatment
A charity has awarded £1.85 million to fund a new research Centre of Excellence at the University of Cambridge as part of its fight to stop multiple... Read More
-
US defence and security market the target for Blighter
Cambridge surveillance technology specialist Blighter has moved to target more contracts in the lucrative US defence and security market by... Read More
-
Azeria Therapeutics liquidated 15 months after raising £32m Series B
A Cambridge startup specialising in a highly complex area of cancer research has decided to close its doors just 15 months or so after raising a £32... Read More
-
Acacia Pharma raises €27m growth capital
Cambridge-based Acacia Pharma Group has raised €27 million through a heavily over-subscribed accelerated bookbuild to fast-track commercialisation of... Read More
-
New £500m technology park set for Cambridge
Abstract (Cambridge) Limited has completed the purchase of a second and adjoining site in Fulbourn Road for its Cambridge International Technology... Read More
-
Cambridge GaN Devices closes $9.5m Series A
Cambridge GaN Devices (CGD) has raised $9.5m Series A funding to accelerate the deployment of energy efficient devices reshaping the future of power... Read More
-
Enval, Kraft Heinz and Sonoco launch CleanTech power play
Cambridge CleanTech business Enval has partnered with two multibillion dollar turnover giants – The Kraft Heinz Co. and Sonoco – to fast-track the... Read More
-
Cambridge launches fight to save the sight of thousands
Business Weekly has joined a campaign to ensure Cambridge-based global disability charity CBM raises crucial cash to help save or restore the sight... Read More
-
Two global gamechangers establish growth platforms at Stevenage site
International companies Galecto Inc. and Rentschler Biopharma have set up operations at the Stevenage Bioscience Catalyst (SBC) and Cell and Gene... Read More
-
CMR cracks German market and says there’s more to come
Cambridge unicorn business CMR Surgical has broken into the lucrative German market with its Versius robotics arm for keyhole surgery. And the... Read More
-
AI scale-up techspert.io ramps globally with Texas office
techspert.io, the Cambridge AI technology innovator connecting businesses with experts for industry insights, has opened its first US office – in... Read More
-
£14.5m market cap for 4basebio on AIM float
Cambridge-based 4basebio UK Societas – a specialist life sciences group – today made its bow on AIM with 12,317,473 ordinary shares in issue and a... Read More
-
New antibody star is born in RxCelerate’s Galaxy
Cambridge drug discovery specialist RxCelerate has launched a game-changing spin-out leveraging a nextgen antibody discovery platform. Galaxy™ is... Read More
-
SPT Labtech extends its California gold rush
Cambridge life science instrumentation business SPT Labtech has acquired California company BioMicroLab for an undisclosed sum. Headquartered in... Read More
-
Cambridge spin-out chosen for Centessa which raises $250m
Orexia Therapeutics – a spin-out business from Sosei Heptares and Medicxi –has been merged into the newly created life sciences power player Centessa... Read More